chartexchange

ATNM
Actinium Pharmaceuticals, Inc
stockNYSEAMERICAN

At CloseNov 17, 2026 3:59:50 PM EST
1.33USD-10.738%(-0.16)553,295
After-hoursNov 17, 2026 4:10:30 PM EST
1.35USD+1.504%(+0.02)
1.1200Bid1.5300Ask0.4100Spread
Loading…
Loading…
Healthcare
Biotechnology
CEO
Sandesh Seth
HQ
New York, NY, USA
Previous Close
$1.49
Beta
0.74
52-Week High
$1.72 2025-12-22
52-Week Low
$0.74 2026-08-05
SMA 50
$1.29
SMA 200
$1.13
Avg. Vol 10D
211,941
Avg. Vol 30D
242,052
Avg. Vol 90D
172,282
Relative Vol
2.28
31.26M
0.5100%
6,954
Aug 11, 2020 · 1-for-30 (reverse)
ATNM Profile

actinium pharmaceuticals, inc. (www.actiniumpharma.com) (nyse mkt: atnm) is a new york-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. the company's lead radiopharmaceutical iomab™-b will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. the company is preparing a single, pivotal, multicenter phase 3 clinical study of iomab™-b in refractory and relapsed acute myeloid leukemia (aml) patients over the age of 55 with a primary endpoint of durable complete remission. the company's second program, actimab-a, is continuing its clinical development in a phase 1/2 trial for newly diagnosed aml patients o

ATNM Performance
PeriodPriceDateChangeBeta
1W1.572026-11-10-15.29%3.155
1M1.132026-10-16+17.70%1.694
3M1.052026-08-17+26.67%1.146
6M1.172026-05-18+13.68%0.645
1Y1.452025-11-17-8.28%0.738
2Y1.422024-11-18-6.34%—
5Y7.782021-11-17-82.91%1.171
ATNM Stock Summary

Actinium Pharmaceuticals, Inc (NYSEAMERICAN:ATNM) stock price today is $1.33, and today's volume is 552,412. ATNM is down 10.738% today. The 30 day average volume is 242,052. ATNM market cap is $41.82M with 31.44M shares outstanding.